PARP3 promotes macrophage inflammation via mono ADP ribosylation of Ppia Glu140
We identified the NF-κB as the downstream signaling pathway mediated by Ppia for PARP3 to promote macrophage inflammation. ME0328 alleviated pulmonary inflammation through the NF-κB signaling pathway. Our findings provide evidence that macrophage inflammation is associated with the mono ADP-ribosylation on Ppia. Understanding mono ADP-ribosylation regulation in macrophage from ALI may provide insight into the pro-inflammatory mechanisms and opportunities for effective therapeutic to treat acute lung injury.
Authors
- Rong Fan (ORCID: https://orcid.org/0000-0002-2061-9762)
- Xiujing Cao (ORCID: https://orcid.org/0000-0003-2418-9920)
- Shuhui Ye
- Wanxin Yao
- Fengyi Gao (ORCID: https://orcid.org/0000-0001-7235-7082)
- Yanmei Zhang (ORCID: https://orcid.org/0000-0002-2237-6637)
- Yue Wu (ORCID: https://orcid.org/0000-0001-5274-3023)
- Guang Liang (ORCID: https://orcid.org/0009-0005-1603-3223)
- Rihong Zhu
Institutions
- Hangzhou Medical College (CN)
Publication Details
- Journal
- Molecular Medicine
- Published
- 2025-06-03
- DOI
- https://doi.org/10.1186/s10020-025-01278-3
- Citations
- 2
- Primary Topic
- PARP inhibition in cancer therapy
- Type
- article
- Field-Weighted Citation Impact
- 2.09